drugset / Trial / NCT00224315

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

NCT00224315

Phase 4 Completed 24 enrolled Central Institute of Mental Health, Mannheim
RandomizedParallel-groupOpen-labelTreatment

Summary

We aim to compare the augmentation of clozapine with ziprasidone or risperidone in a randomized, prospective manner.

Timeline

Start
2003-11
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified
Subject Ziprasidone Small molecule

Indications